| Literature DB >> 31820260 |
Karim Hader1,2, Michael C Rumpf3,4, Maxime Hertzog1, Liam P Kilduff5,6, Olivier Girard7, Joao R Silva8,9.
Abstract
BACKGROUND: Monitoring athletes' external load during a soccer match may be useful to predict post-match acute and residual fatigue. This estimation would allow individual adjustments to training programs to minimize injury risk, improve well-being, and restore players' physical performance and inform the recovery process.Entities:
Keywords: External load; Monitoring, Fatigue; Muscle damage; Neuromuscular performance; Perceptual responses; Recovery; Time motion analysis
Year: 2019 PMID: 31820260 PMCID: PMC6901634 DOI: 10.1186/s40798-019-0219-7
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Database search strategy
| 1.“soccer match” OR “football match” | |
| 2.“locomotor activity” OR “match activity” OR “match load” OR “external load” OR “monitoring” | |
| 3.“muscle damage” OR “creatine kinase” OR “biochemical markers” | |
| 4.“muscle performance” OR “jump” OR “strength” OR “power” OR “neuromuscular” | |
| 5.“fatigue” OR “recovery” OR “perceptual” OR “soreness” OR “perceived exertion” OR “internal load” OR “psychometric” | |
| (1 AND 2 AND 3) OR (1 AND 2 AND 4) OR (1 AND 2 AND 5) |
Quality assessment criteria
| No. | Items | Scoring | ||
|---|---|---|---|---|
| 0 | 1 | 2 | ||
| 1 | Was the main question or objective clearly described? | No | Yes | |
| 2 | Was the study population clearly specified and defined (age, gender, training status, stated inclusion/exclusion criteria)? | No | Partly | Yes |
| 3 | Was the sample size justified? | No | Yes | |
| 4 | Main measured variables clearly described in the Introduction or Method section? | No | Partly | Yes |
| 5 | Locomotor activity variables clearly defined (thresholds, ranges). | No | Partly | Yes |
| 6 | Were the validity and reliability of the main variables measurements discussed? | No | Partly | Yes |
| 7 | Were the methods (included the statistical methods) sufficiently described to enable the study replication? | No | Partly | Yes |
| 8 | Does the study provide estimates of the random variability in the data for the main outcomes (i.e. confidence intervals, standard deviations)? | No | Partly | Yes |
| 9 | Were all the tested associations reported? | No | Yes | |
| 10 | Were the study limitations discussed? | No | Partly | Yes |
Characteristics of the selected studies
| Studies | Players details (level, | Tracking systems | External load metrics examined | Fatigue-related dependent variables investigated | Quality assessment score |
|---|---|---|---|---|---|
| Aquino et al., [ | Elite/18/15.6 ± 0.4 | Video analysis "tracking software DVIDEOW" | Medium running distance (8.1–13 km h−1); HI running distance (13.1–18 km h−1); Sprinting distance (> 18 km h−1); HI activity distance (> 13 km h−1); TD; Number of sprints. | Pre- to post-match % change in CK concentration Pre- to post-match % change in LDH concentration | 0.65 |
| De Hoyo et al., [ | Elite/15/18 ± 1 | 15-Hz GPS with 100-Hz accelerometer | Medium intensity (14–17.9 km h−1), HI (18-20.9 km h−1) and sprinting (> 21 km h−1) distances; High-speed (> 14 km h−1) and very high-speed running (> 18 km h−1); number of medium to high (> 2 m/s2) and high (> 3 m/s2) accelerations; number of medium to high (< − 2 m/s2) and high decelerations (< − 3 m/s2); TD; Impacts (> 7.1G) | Pre to post-match changes at ~ 30 min, G + 24H and G + 48H in: CK concentration Average concentric and eccentric force during CMJ CMJ height | 0.70 |
| Draganidis et al., [ | Semi-professional/20/ 22.6 ± 1.5 | 5-Hz GPS with 100-Hz accelerometer | HI running (>14.5 km h−1); VHI running (>19.8 km h−1) and sprinting (>25.2 km h−1); number of low, medium and HI accelerations (1–2 m/s2, 2–3 m/s2, > 3 m/s2); Number of low, medium and HI decelerations (− 1 to − 2 m/s2, − 2 to − 3 m/s2, < − 3 m/s2); TD | Pre to G + 24H, G + 48H and G + 72H changes in: CK concentration Leucocytes count Concentric and eccentric isokinetic peak torque at 60°/s and 180°/s MVIC of KE and KF muscles DOMS | 0.80 |
| Nedelec et al., [ | Professional/14/ 21.8 ± 3.2 | Video analysis | High acceleration and deceleration <5 m High acceleration and deceleration >5 m HI running Hard changes of direction | Pre to G + 24H, G + 48H and G + 72H post-match changes in: CMJ performance MVIC of the hamstring with knee flexed at 90° and 150° KF muscle soreness | 0.65 |
| Rampinini et al., [ | Professional/20/19 ± 1 | Video-computerized, semi-automatic match analysis | TD HI running (> 15 km h−1) | Pre to immediately, G + 24H and G + 48H % changes in: Maximal voluntary activation (%VA) Normalized Root mean square of vastus lateralis muscle EMG signal during MVIC. Peak torque with 1-ms, 10-ms interval and 100-ms interval stimulations | 0.70 |
| Romagnoli et al., [ | Professional/20/17- 20 | Video-computerized, semi-automatic match analysis | TD Low-intensity running distance (< 15 km h−1) HI running distance (> 15 km h−1) VHI running distance (> 20 km h−1) | Pre to 30 min, G + 24H and G + 48H changes in: White blood cells count Cortisol and Testosterone concentrations Creatine kinase concentration | 0.40 |
| Russell et al., [ | Professional/15/ 20 ± 1 | 10-Hz GPS units | Raw and normalized (per min) TD Raw and normalized (per min) HI running distance (> 19.8 km h−1) Raw and normalized (per min) total number of: sprints (> 19.8 km h−1), high accelerations, high decelerations, HI impacts Total number of accelerations, decelerations and impacts. | Pre to G + 24H and G + 48H changes in: CK concentration CMJ PPO | 0.80 |
| Scott et al., [ | Professional/15/26 ± 4 | video-computerized, semi-automatic match analysis | TD, HI running (> 19.8 km h−1) and Sprinting (> 25.2 km h−1): distances and occurrences | Pre to G + 48H changes in CK concentration | 0.75 |
| Shearer et al., [ | Elite/11/20 ± 1 | 10-Hz GPS units | Raw and normalized (per min) TD Raw and normalized (per min) HI running distance (> 19.8 km h−1) Raw and normalized (per min) total number of sprints (> 19.8 km h−1) | Pre to G + 24H and G + 48H changes in: CK concentration CMJ PPO Brief assessment of mood | 0.75 |
| Thorpe et al., [ | Semi-professional/7/25 ± 6 | 1-Hz GPS unit with 100-Hz accelerometer | Walking distance (0–6 km h−1); jogging distance (6–8 km h−1); low-speed running (8–12 km h−1); moderate-speed running (12–15 km h−1); Fast speed running (15–18 km h−1); sprinting distance (>18 km h−1); HI activity (> 15 km h−1); total number of sprints. | Pre to post-match changes in: CK concentration Myoglobin concentration Cortisol and Testosterone concentrations | 0.70 |
| Varley et al., [ | Professional/10/27 ± 3 | Video-computerized, semi-automatic match analysis | TD, sprint distance (> 25.2 km h−1), total number of: sprints), high accelerations, high decelerations. | Pre to immediately, G + 48H and G + 72H changes in: CK concentration CMJ height Muscle fatigue and wellness | 0.85 |
n: number of players, TD: total distance, KE: knee extension, KF: knee flexion, CMJ: countermovement jump, PPO: peak power output, PT: peak torque, DOMS: delayed onset muscle soreness, HI: high intensity, VHI: very high intensity, MVIC: maximal voluntary isometric contraction
Summary of findings from meta-analysis describing the relationship between external load metrics of level 1 [3] and fatigue-related markers
| Predictors | Fatigue-related markers | Time | ṝ | Lower CL | Upper CL | Number of studies/correlations | Evidence | chi2 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TD | Muscle damage | Post | 0.36 | 0.05 | 0.67 | 5/3 | Limited | 48 | 66 | 2.95 | 0.09 |
| G + 24H | 0.36 | 0.19 | 0.53 | 5/6 | Limited | 87 | 0 | 4.73 | 0.45 | ||
| G + 48H | 0.23 | 0.05 | 0.42 | 6/7 | Moderate | 97 | 0 | 4.81 | 0.44 | ||
| G + 72H | − 0.02 | 1/1 | No | 10 | |||||||
| CMJPPO | G + 24H | − 0.16 | − 0.47 | 0.15 | 2/5 | Conflicted | 67 | 41 | 7.83 | 0.10 | |
| G + 48H | 0.09 | − 0.08 | 0.27 | 2/5 | Moderate | 67 | 0 | 2.46 | 0.65 | ||
| CMJ performance | G + 48H | 0.04 | 1/1 | No | 10 | ||||||
| G + 72H | − 0.06 | 1/1 | No | 10 | |||||||
| Leucocytes count | G + 24H | − 0.10 | 2/1 | No | 39 | ||||||
| G + 48H | 0.21 | 2/1 | No | 39 | |||||||
| G + 72H | 0.09 | 2/1 | No | 39 | |||||||
| Cortisol | Post | NS | 1/0 | No | |||||||
| G + 24H | 0.50 | 1/1 | Limited | 20 | |||||||
| G + 48H | 0.52 | 1/1 | Limited | 20 | |||||||
| Testosterone | Post | NS | 1/1 | No | 20 | ||||||
| G + 24H | NS | 1/1 | No | 20 | |||||||
| G + 48H | NS | 1/1 | No | 20 | |||||||
| PT 1 Hz | Post | − 0.19 | 1/1 | No | 19 | ||||||
| PT 10 Hz | Post | − 0.20 | 1/1 | No | 19 | ||||||
| PT 100 Hz | Post | − 0.17 | 1/1 | No | 19 | ||||||
| DOMS | G + 24H | − 0.04 | 1/1 | No | 20 | ||||||
| G + 48H | 0.06 | 1/1 | No | 20 | |||||||
| G + 72H | 0.04 | 1/1 | No | 20 | |||||||
| PT Concentric KE | G + 24H | − 0.68 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.43 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.42 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.76 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.65 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.58 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.59 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.40 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.44 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.82 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.58 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.56 | 1/1 | Limited | 20 | |||||||
| BAM+ | G + 24H | 0.09 | 1/1 | No | 35 | ||||||
| G + 48H | 0.14 | 1/1 | No | 35 | |||||||
| TD/min | Muscle damage | G + 24H | 0.13 | 0.05 | 0.26 | 2/2 | Limited | 67 | |||
| G + 48H | − 0.06 | 0.00 | − 0.11 | 2/2 | Limited | 67 | |||||
| CMJPPO | G + 24H | − 0.03 | − 0.05 | − 0.01 | 2/2 | Limited | 67 | ||||
| G + 48H | − 0.11 | − 0.11 | − 0.10 | 2/2 | Limited | 67 | |||||
| BAM+ | G + 24H | − 0.47 | 1/1 | Limited | 35 | ||||||
| G + 48H | − 0.51 | 1/1 | Limited | 35 | |||||||
| HIR | Muscle damage | Post | 0.55 | 0.33 | 0.78 | 5/3 | Moderate | 45 | 59 | 3.40 | 0.18 |
| G + 24H | 0.37 | 3/ 1 | Limited | 20 | |||||||
| G + 48H | 0.37 | 0.21 | 0.53 | 3/2 | Limited | 35 | 0 | 0.57 | 0.45 | ||
| MVIC Dom | G + 24H | − 0.55 | 2/1 | Limited | 20 | ||||||
| G + 48H | 0.43 | 2/1 | Limited | 20 | |||||||
| G + 72H | 0.46 | 2/1 | Limited | 20 | |||||||
| DOMS | G + 24H | − 0.03 | 2/1 | No | 34 | ||||||
| G + 48H | 0.00 | 2/1 | No | 34 | |||||||
| G + 72H | 0.04 | 2/1 | No | 34 | |||||||
| Leucocytes count | G + 24H | − 0.11 | 2/1 | No | 39 | ||||||
| G + 48H | 0.21 | 2/1 | No | 39 | |||||||
| Cortisol | Post | NS | 2/0 | No | |||||||
| G + 24H | NS | 1/0 | No | ||||||||
| G + 48H | NS | 1/0 | No | ||||||||
| Testosterone | Post | NS | 2/0 | No | |||||||
| G + 24H | NS | 1/0 | No | ||||||||
| G + 48H | NS | 1/0 | No | ||||||||
| PT 1 Hz | Post | − 0.22 | 1/1 | No | 19 | ||||||
| PT 10 Hz | Post | − 0.24 | 1/1 | No | 19 | ||||||
| PT 100 Hz | Post | − 0.20 | 1/1 | No | 19 | ||||||
| PT Concentric KE | G + 24H | − 0.69 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.46 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.45 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.77 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.68 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.59 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.59 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.43 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.46 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.83 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.60 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.58 | 1/1 | Limited | 20 | |||||||
| VHIR | Muscle damage | Post | 0.67 | 0.40 | 0.94 | 5/3 | Moderate | 45 | 77 | 8 | 0.02 |
| G + 24H | 0.54 | 0.35 | 0.65 | 5/6 | Strong | 87 | 0 | 2.80 | 0.73 | ||
| G + 48H | 0.36 | 0.19 | 0.53 | 5/7 | Moderate | 87 | 0 | 4.55 | 0.47 | ||
| CMJPPO | G + 24H | − 0.52 | − 0.64 | − 0.40 | 2/5 | Strong | 67 | 0 | 2.21 | 0.70 | |
| G + 48H | − 0.25 | − 0.48 | − 0.02 | 2/5 | Limited | 67 | 0 | 4.63 | 0.33 | ||
| MVIC Dom | G + 24H | − 0.57 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.45 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.43 | 1/1 | Limited | 20 | |||||||
| Leucocytes count | G + 24H | − 0.12 | 2/1 | No | 39 | ||||||
| G + 48H | 0.19 | 2/1 | No | 39 | |||||||
| BAM+ | G + 24H | − 0.21 | 1/1 | No | 35 | ||||||
| G + 48H | − 0.17 | 1/1 | No | 35 | |||||||
| Cortisol | Post | NS | 2/0 | No | |||||||
| G + 24H | NS | 1/0 | No | ||||||||
| G + 48H | NS | 1/0 | No | ||||||||
| Testosterone | Post | NS | 2/0 | No | |||||||
| G + 24H | NS | 1/0 | No | ||||||||
| G + 48H | NS | 1/0 | No | ||||||||
| CMJ performance | Post | NS | 1/0 | No | |||||||
| G + 24H | NS | 1/0 | No | ||||||||
| G + 48H | NS | 1/0 | No | ||||||||
| DOMS | G + 24H | 0.07 | 1/1 | No | 20 | ||||||
| G + 48H | 0.07 | 1/1 | No | 20 | |||||||
| G + 72H | − 0.10 | 1/1 | No | 20 | |||||||
| PT Concentric KE | G + 24H | − 0.69 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.51 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.51 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.78 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.72 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.61 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.59 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.51 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.48 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.83 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.63 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.62 | 1/1 | Limited | 20 | |||||||
| VHIR dist/min | Muscle damage | G + 24H | 0.37 | 0.11 | 0.55 | 2/5 | Limited | 67 | |||
| G + 48H | 0.13 | 0.05 | 0.31 | 2/5 | Limited | 67 | |||||
| CMJPPO | G + 24H | − 0.22 | − 0.48 | − 0.03 | 2/5 | Limited | 67 | ||||
| G + 48H | − 0.25 | − 0.53 | 0.05 | 2/5 | Limited | 67 | |||||
| BAM+ | G + 24H | − 0.44 | 1/1 | Limited | 35 | ||||||
| G + 48H | − 0.40 | 1/1 | Limited | 35 | |||||||
| VHIR runs/min | Muscle damage | G + 24H | 0.24 | 0.06 | 0.42 | 2/5 | Limited | 67 | |||
| G + 48H | 0.11 | − 0.05 | 0.29 | 2/5 | Limited | 67 | |||||
| CMJ peak power | G + 24H | − 0.22 | − 0.49 | − 0.05 | 2/5 | Limited | 67 | ||||
| G + 48H | − 0.20 | − 0.41 | − 0.02 | 2/5 | Limited | 67 | |||||
| Cortisol | Post | NS | 1/1 | No | |||||||
| Testosterone | Post | NS | 1/1 | No | |||||||
| BAM+ | G + 24H | − 0.55 | 1/1 | Limited | 35 | ||||||
| G + 48H | − 0.49 | 1/1 | Limited | 35 | |||||||
| Sprint | Muscle damage | Post | 0.12 | 2/1 | Limited | 35 | |||||
| G + 24H | 0.40 | 2/1 | Limited | 35 | |||||||
| G + 48H | 0.38 | 3/2 | Limited | 45 | |||||||
| G + 72H | − 0.02 | 1/1 | Limited | 10 | |||||||
| MVIC | G + 24H | − 0.51 | 2/1 | Limited | 20 | ||||||
| G + 48H | 0.35 | 2/1 | Limited | 20 | |||||||
| G + 72H | 0.35 | 2/1 | Limited | 20 | |||||||
| Leucocyte count | G + 24H | − 0.10 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.17 | 1/1 | Limited | 20 | |||||||
| G + 72H | − 0.23 | 1/1 | Limited | 20 | |||||||
| DOMS | G + 24H | 0.31 | 2/2 | Limited | 20 | ||||||
| G + 48H | 0.05 | 2/1 | Limited | 20 | |||||||
| G + 72H | − 0.37 | 2/1 | Limited | 20 | |||||||
| PT Concentric KE | G + 24H | − 0.58 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.55 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.58 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.70 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.70 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.56 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.45 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.64 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.45 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.68 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.63 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.61 | 1/1 | Limited | 20 | |||||||
| CMJ performance | Post | NS | 2/0 | No | |||||||
| G + 24H | NS | 2/0 | No | ||||||||
| G + 48H | 0.27 | 3/1 | No | 10 | |||||||
| G + 72H | 0.27 | 3/1 | No | 10 | |||||||
| TQR | G + 24H | NS | 1/0 | No | |||||||
| G + 48H | NS | 1/0 | No | ||||||||
| G + 72H | NS | 1/0 | No |
ṝ : pooled correlation from Hunter and Schmidt random-effects method, CL: confidence limit, N: number of players, TD: total distance, KE: knee extension, KF: knee flexion, CMJ: countermovement jump, CMJPPO: countermovement jump peak power, PT: peak torque, DOMS: delayed onset muscle soreness, BAM+: brief assessment of the mood, HIR: high-intensity running (> 4 m s−1), MVIC: maximal voluntary isometric contraction, VHIR: very high-intensity running (> 5.5 m s−1), conc: concentric, ecc: eccentric, Acc: acceleration, Decel: deceleration, No: no evidence, NS: not specified, PT 1–100 Hz: peak torque induced by single (1 Hz) and paired electrical stimuli (10 and 100 Hz)
Summary of findings from meta-analysis describing the relationship between external load metrics (levels 2 and 3) [3] and fatigue-related markers
| Predictors | Fatigue-related markers | Time | Lower CL | Upper CL | Number of studies/correlations | Evidence | chi2 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HI Acc | Muscle damage | Post | 0.24 | 0.02 | 0.46 | 2/1 | Limited | 45 | |||
| G + 24H | 0.41 | 0.30 | 0.51 | 3/5 | Moderate | 52 | 0 | 0.97 | 0.91 | ||
| G + 48H | 0.30 | 0.15 | 0.45 | 3/6 | Moderate | 77 | 0 | 2.95 | 0.71 | ||
| G + 72H | 0.01 | 1/1 | Limited | 10 | |||||||
| CMJPPO | G + 24H | − 0.61 | − 0.79 | − 0.42 | 2/5 | Strong | 46 | 24 | 4 | 0.41 | |
| G + 48H | − 0.36 | − 0.68 | − 0.05 | 2/4 | Limited | 32 | 0 | 3.71 | 0.29 | ||
| MVIC | G + 24H | − 0.79 | 2/1 | Limited | 34 | ||||||
| G + 48H | 0.74 | 2/1 | Limited | 34 | |||||||
| G + 72H | 0.46 | 2/1 | Limited | 34 | |||||||
| DOMS | G + 24H | − 0.05 | 3/1 | Limited | 20 | ||||||
| G + 48H | 0.23 | − 0.27 | 0.73 | 3/2 | Limited | 34 | 79 | 4.04 | 0.04 | ||
| G + 72H | 0.23 | − 0.11 | 0.56 | 3/2 | Limited | 34 | 43 | 1.84 | 0.17 | ||
| CMJ performance | G + 24H | NS | 2/0 | No | |||||||
| G + 48H | 0.27 | 3/1 | Limited | 10 | |||||||
| G + 72H | 0.09 | 1/1 | Limited | 10 | |||||||
| Leucocytes count | G + 24H | 0.17 | 1/1 | Limited | 20 | ||||||
| G + 48H | − 0.14 | 1/1 | Limited | 20 | |||||||
| G + 72H | − 0.02 | 1/1 | Limited | 20 | |||||||
| PT Concentric KE | G + 24H | − 0.75 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.52 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.56 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.84 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.70 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.58 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.64 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.51 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.41 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.89 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.62 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.69 | 1/1 | Limited | 20 | |||||||
| TQR | G + 24H | NS | 1/0 | No | |||||||
| G + 48H | NS | 1/0 | No | ||||||||
| G + 72H | NS | 1/0 | No | ||||||||
| Mod to HI Acc | Muscle damage | Post | 0.34 | 2/1 | Limited | 35 | |||||
| G + 24H | 0.32 | 2/1 | Limited | 35 | |||||||
| G + 48H | 0.27 | 2/1 | Limited | 35 | |||||||
| CMJ conc force | G + 48H | − 0.49 | − 0.78 | − 0.17 | 1/1 | Limited | 35 | ||||
| CMJ ecc force | Post | − 0.47 | − 0.73 | − 0.11 | 1/1 | Limited | 35 | ||||
| MVIC | G + 24H | − 0.74 | 1/1 | Limited | 35 | ||||||
| G + 48H | 0.80 | 1/1 | Limited | 35 | |||||||
| G + 72H | 0.49 | 1/1 | Limited | 35 | |||||||
| DOMS | G + 24H | − 0.04 | 1/1 | Limited | 35 | ||||||
| G + 48H | − 0.02 | 1/1 | Limited | 35 | |||||||
| G + 72H | − 0.04 | 1/1 | Limited | 35 | |||||||
| PT Concentric KE | G + 24H | − 0.75 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.56 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.64 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.84 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.70 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.57 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.60 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.57 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.47 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.85 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.65 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.68 | 1/1 | Limited | 20 | |||||||
| HI Decel | Muscle damage | Post | 0.32 | 0.13 | 0.51 | 3/2 | Limited | 45 | |||
| G + 24H | 0.47 | 0.36 | 0.59 | 5/6 | Strong | 52 | 0 | 1.26 | 0.87 | ||
| G + 48H | 0.37 | 0.18 | 0.55 | 6/7 | Moderate | 67 | 0 | 4.8 | 0.44 | ||
| G + 72H | 0.00 | 1/1 | Limited | 10 | |||||||
| CMJPPO | G + 24H | − 0.59 | − 0.78 | 0.40 | 1/4 | Limited | 32 | 0 | 2.49 | 0.48 | |
| G + 48H | − 0.11 | − 0.42 | 0.19 | 1/4 | Limited | 32 | 0 | 2.63 | 0.45 | ||
| CMJ performance | G + 24H | NS | 1/0 | No | |||||||
| G + 48H | 0.15 | 2/1 | Limited | 10 | |||||||
| G + 72H | 0.16 | 1/1 | Limited | 10 | |||||||
| MVIC | G + 24H | − 0.78 | 2/1 | Limited | 34 | ||||||
| G + 48H | 0.70 | 2/1 | Limited | 34 | |||||||
| G + 72H | 0.46 | 2/1 | Limited | 34 | |||||||
| DOMS | G + 24H | − 0.11 | 2/1 | Limited | 34 | ||||||
| G + 48H | 0.08 | 2/1 | Limited | 34 | |||||||
| PT Concentric KE | G + 24H | − 0.82 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.43 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.59 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.84 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.70 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.58 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.55 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.53 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.53 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.82 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.62 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.65 | 1/1 | Limited | 20 | |||||||
| Leucocytes count | G + 24H | 0.22 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.14 | 1/1 | Limited | 20 | |||||||
| G + 72H | − 0.04 | 1/1 | Limited | 20 | |||||||
| TQR | G + 24H | NS | 1/0 | No | |||||||
| G + 48H | NS | 1/0 | No | ||||||||
| G + 72H | NS | 1/0 | No | ||||||||
| Mod to HI Decel | Muscle damage | Post | 0.14 | 2/1 | Limited | 35 | |||||
| G + 24H | 0.03 | 2/1 | Limited | 35 | |||||||
| G + 48H | 0.25 | 2/2 | Limited | 67 | |||||||
| MVIC | G + 24H | − 0.80 | 1/1 | Limited | 35 | ||||||
| G + 48H | 0.76 | 1/1 | Limited | 35 | |||||||
| G + 72H | 0.39 | 1/1 | Limited | 35 | |||||||
| CMJ conc force | G + 48H | − 0.49 | − 0.78 | − 0.17 | 1/1 | Limited | 35 | ||||
| CMJ ecc force | Post | − 0.47 | − 0.73 | − 0.11 | 1/1 | Limited | 35 | ||||
| DOMS | G + 24H | − 0.14 | 1/1 | Limited | 35 | ||||||
| G + 48H | 0.06 | 1/1 | Limited | 35 | |||||||
| G + 72H | 0.10 | 1/1 | Limited | 35 | |||||||
| PT Concentric KE | G + 24H | − 0.82 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.40 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.59 | 1/1 | Limited | 20 | |||||||
| PT Concentric KF | G + 24H | − 0.83 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.64 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.57 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KE | G + 24H | − 0.54 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.53 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.42 | 1/1 | Limited | 20 | |||||||
| PT Eccentric KF | G + 24H | − 0.84 | 1/1 | Limited | 20 | ||||||
| G + 48H | 0.57 | 1/1 | Limited | 20 | |||||||
| G + 72H | 0.71 | 1/1 | Limited | 20 | |||||||
| High Impact | Muscle damage | G + 24H | 0.19 | − 0.14 | 0.51 | 2/4 | Limited | 47 | 0 | 3.17 | 0.37 |
| G + 48H | 0.15 | − 0.22 | 0.53 | 2/4 | Limited | 47 | 0 | 4.17 | 0.24 | ||
| CMJPPO | G + 24H | − 0.32 | − 0.61 | − 0.03 | 2/4 | Limited | 50 | 5 | 5.60 | 0.23 | |
| G + 48H | 0.04 | − 0.30 | 0.38 | 1/4 | Limited | 32 | 0 | 3.25 | 0.36 |
ṝ : pooled correlation from Hunter and Schmidt random-effects method, CL: confidence limit, N: number of players, TD: total distance, KE: knee extension, KF: knee flexion, CMJ: countermovement jump, CMJ: countermovement jump peak power, PT: peak torque, DOMS: delayed onset muscle soreness, TQR: total quality of recovery, BAM+: brief assessment of the mood, HI: high intensity, Mod: moderate, MVIC: maximal voluntary isometric contraction, conc: concentric, ecc: eccentric, Acc: acceleration, Decel: deceleration, No: no evidence, Conf: conflicted
Fig. 2Relationship between match-related running distance above 5.5 m s−1 and post-match changes in CK (upper panel) and CMJ peak power output (lower panel). CK: creatine kinase; CMJ: countermovement jump
Fig. 1PRISMA flow chart